Statistical approaches and policies for the operations of Data and Safety Monitoring Committees
- 1 February 2001
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 141 (2) , 301-305
- https://doi.org/10.1067/mhj.2001.113152
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific IssuesAnnals of Internal Medicine, 2000
- The agonising negative trend in monitoring of clinical trialsThe Lancet, 1999
- Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast CancerJNCI Journal of the National Cancer Institute, 1997
- Randomised study of effect of ibopamine on survival in patients with advanced severe heart failureThe Lancet, 1997
- Trials to assess equivalence: the importance of rigorous methodsBMJ, 1996
- Problems in interpreting active control equivalence trialsAccountability in Research, 1996
- The what, why and how of bayesian clinical trials monitoringStatistics in Medicine, 1994
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Practical aspects of decision making in clinical trials: The coronary drug project as a case studyControlled Clinical Trials, 1981